| Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a … SYC Tong, DC Lye, D Yahav, A Sud, JO Robinson, J Nelson, S Archuleta, ... Jama 323 (6), 527-537, 2020 | 199* | 2020 |
| Gut microbiomes from Gambian infants reveal the development of a non-industrialized Prevotella-based trophic network MC de Goffau, AT Jallow, C Sanyang, AM Prentice, N Meagher, DJ Price, ... Nature microbiology 7 (1), 132-144, 2022 | 43 | 2022 |
| Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label … JR Poespoprodjo, FH Burdam, F Candrawati, B Ley, N Meagher, ... The Lancet Infectious Diseases 22 (3), 367-376, 2022 | 25 | 2022 |
| Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study A Devine, KE Battle, N Meagher, RE Howes, S Dini, PW Gething, ... PLoS Medicine 18 (6), e1003614, 2021 | 21 | 2021 |
| Whole genome sequencing for tuberculosis in Victoria, Australia: a genomic implementation study from 2017 to 2020 K Dale, M Globan, K Horan, N Sherry, S Ballard, EL Tay, S Bittmann, ... The Lancet Regional Health–Western Pacific 28, 2022 | 11 | 2022 |
| Transmission of SARS-CoV-2 in standardised First Few X cases and household transmission investigations: a systematic review and meta-analysis HC Lewis, AJ Marcato, N Meagher, M Valenciano, ... Influenza and Other Respiratory Viruses 16 (5), 803-819, 2022 | 11 | 2022 |
| Adding saliva testing to oropharyngeal and deep nasal swab testing increases PCR detection of SARS‐CoV‐2 in primary care and children J Oliver, S Tosif, L Lee, AM Costa, C Bartel, K Last, V Clifford, A Daley, ... Medical Journal of Australia 215 (6), 273-278, 2021 | 11 | 2021 |
| Clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation (CASSETTE)—an open-labelled pilot randomized controlled trial AJ Campbell, R Dotel, M Braddick, PN Britton, DP Eisen, JR Francis, ... JAC-Antimicrobial Resistance 4 (1), dlac014, 2022 | 9 | 2022 |
| Promoting resilience while mitigating disease transmission: An Australian COVID-19 study FM Shearer, N Meagher, KM Chavez, L Carpenter, A Pirrone, P Quinn, ... COVID-19 pandemic, geospatial Information, and community resilience, 347-362, 2021 | 8 | 2021 |
| Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial A Legg, N Meagher, SA Johnson, MA Roberts, A Cass, MH Scheetz, ... Clinical Drug Investigation 43 (1), 23-33, 2023 | 6 | 2023 |
| Inclusion of cultural and linguistic diversity in COVID-19 public health research: research design adaptations to seek different perspectives in Victoria, Australia L Gibbs, AJ Thomas, A Coelho, A Al-Qassas, K Block, N Meagher, L Eisa, ... International Journal of Environmental Research and Public Health 20 (3), 2320, 2023 | 5 | 2023 |
| Learnings from the Australian first few X household transmission project for COVID-19 AJ Marcato, AJ Black, CR Walker, D Morris, N Meagher, DJ Price, ... The Lancet Regional Health–Western Pacific 28, 2022 | 5 | 2022 |
| Distancing Measures in the Face of COVID-19 in Australia: Summary of National Survey Findings N Meagher, L Carpenter, K Marinkovic Chavez, M Vasileva, ... Melbourne, VIC: Melbourne School of Population and Global Health, University …, 2020 | 5 | 2020 |
| SARS-CoV-2 seroepidemiology in Mongolia, 2020–2021: a longitudinal national study B Chimeddorj, CR Bailie, U Mandakh, DJ Price, B Bayartsogt, N Meagher, ... The Lancet Regional Health–Western Pacific 36, 2023 | 4 | 2023 |
| Household transmission investigation: Design, reporting and critical appraisal DJ Price, V Spirkoska, AJ Marcato, N Meagher, JE Fielding, A Karahalios, ... Influenza and Other Respiratory Viruses 17 (6), e13165, 2023 | 4 | 2023 |
| Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg‐positive chronic … J Wagner, L Yuen, M Littlejohn, V Sozzi, K Jackson, R Martin, ... Alimentary Pharmacology & Therapeutics 57 (5), 509-523, 2023 | 2 | 2023 |
| Distancing Measures in the Face of COVID-19 in Australia FM Shearer, L Gibbs, E Alisic, KM Chavez, N Meagher, LCP Quinn, ... Summary of National Survey Findings. Survey 2, 2020 | 2 | 2020 |
| Priority populations’ experiences of isolation, quarantine and distancing for COVID-19: protocol for a longitudinal cohort study (Optimise Study) A Pedrana, A Bowring, K Heath, AJ Thomas, A Wilkinson, ... BMJ open 14 (1), e076907, 2024 | 1 | 2024 |
| One Health pandemic preparedness: the role of companion animals in disease transmission AJ Marcato, N Meagher, V Spirkoska, A Arnott, J McVernon, DJ Price, ... Lancet (London, England) 403 (10440), 1984-1985, 2024 | | 2024 |
| Intermittent preventive treatment with sulphadoxine-pyrimethamine but not dihydroartemisinin-piperaquine modulates the relationship between inflammatory markers and adverse … K Cheng, EH Aitken, W Hasang, N Meagher, DJ Price, M Madanitsa, ... PLOS Global Public Health 4 (5), e0003198, 2024 | | 2024 |
David J. PriceSenior Research Fellow at University of MelbourneVahvistettu sähköpostiosoite verkkotunnuksessa unimelb.edu.au
